BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHGE BiomX Inc.

盘后交易 12-19 16:53:45 EST

2.13

+0.25

+13.30%

盘后2.08

-0.05-2.18%

16:48 EST

最高2.23	最低1.86	成交量9.32万
今开1.86	昨收1.88	日振幅19.68%
总市值325.17万	流通市值219.73万	总股本152.66万
成交额19.07万	换手率9.04%	流通股本103.16万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHGE","market":"US","secType":"STK","nameCN":"BiomX Inc.","latestPrice":2.13,"timestamp":1766178000000,"preClose":1.88,"halted":0,"volume":93221,"hourTrading":{"tag":"盘后","latestPrice":2.0836,"preClose":2.13,"latestTime":"16:48 EST","volume":212,"amount":443.1952644,"timestamp":1766180917069},"delay":0,"floatShares":1031605,"shares":1526640,"eps":-38.20881,"marketStatus":"盘后交易","change":0.25,"latestTime":"12-19 16:53:45 EST","open":1.86,"high":2.2299,"low":1.86,"amount":190713.0785907,"amplitude":0.196755,"askPrice":2.16,"askSize":50,"bidPrice":2.08,"bidSize":113,"shortable":3,"etf":0,"ttmEps":-38.20881,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766192400000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":1.88,"preHourTrading":{"tag":"盘前","latestPrice":1.83,"preClose":1.88,"latestTime":"09:23 EST","volume":883,"amount":1713.044724,"timestamp":1766154222209},"postHourTrading":{"tag":"盘后","latestPrice":2.0836,"preClose":2.13,"latestTime":"16:48 EST","volume":212,"amount":443.1952644,"timestamp":1766180917069},"volumeRatio":0.913169},"requestUrl":"/m/hq/s/PHGE","defaultTab":"news","newsList":[{"id":"1110392234","title":"BiomX Inc.收到FDA有关第三方雾化器设备的进一步问询，设备用于Bx004的给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1110392234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110392234?lang=zh_cn&edition=full","pubTime":"2025-11-26 05:42","pubTimestamp":1764106953,"startTime":"0","endTime":"0","summary":"BiomX Inc.收到FDA有关第三方雾化器设备的进一步问询，设备用于Bx004的给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"1150199749","title":"BiomX Inc.：与设备制造商紧密合作，汇总机构对Bx004的剩余信息要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1150199749","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150199749?lang=zh_cn&edition=full","pubTime":"2025-11-26 05:42","pubTimestamp":1764106951,"startTime":"0","endTime":"0","summary":"BiomX Inc.：与设备制造商紧密合作，汇总机构对Bx004的剩余信息要求","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2586280365","title":"Biomx Inc.盘中异动 早盘急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586280365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586280365?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:33","pubTimestamp":1764081238,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时33分，Biomx Inc.股票出现异动，股价大幅下跌5.20%。截至发稿，该股报5.20美元/股，成交量1620股，换手率0.11%，振幅1.73%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223358977ec8b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223358977ec8b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2583159639","title":"Biomx Inc.盘中异动 早盘股价大涨5.03%报0.368美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583159639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583159639?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:11","pubTimestamp":1763133108,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时11分，Biomx Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报0.368美元/股，成交量25.2091万股，换手率0.95%，振幅5.63%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114231148a6f9d533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114231148a6f9d533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2582347259","title":"Biomx Inc.盘中异动 大幅拉升5.17%报0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582347259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582347259?lang=zh_cn&edition=full","pubTime":"2025-11-12 02:08","pubTimestamp":1762884492,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时08分，Biomx Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报0.411美元/股，成交量65.1235万股，换手率2.45%，振幅4.68%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120208139762f993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120208139762f993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2581729157","title":"Biomx Inc.盘中异动 股价大跌8.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581729157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581729157?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:31","pubTimestamp":1762266666,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时31分，Biomx Inc.股票出现异动，股价大幅跳水8.07%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104223106a6e0b544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104223106a6e0b544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"1127250552","title":"BiomX：预计不再进行额外的非临床研究，FDA对CMC的意见与现有的制造与质量战略一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1127250552","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127250552?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:42","pubTimestamp":1762263733,"startTime":"0","endTime":"0","summary":"BiomX：预计不再进行额外的非临床研究，FDA对CMC的意见与现有的制造与质量战略一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"1152750377","title":"BiomX宣布获得FDA积极反馈，支持其用于糖尿病足感染的下一代噬菌体鸡尾酒项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1152750377","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152750377?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:41","pubTimestamp":1762263678,"startTime":"0","endTime":"0","summary":"BiomX宣布获得FDA的积极反馈，支持其针对糖尿病足感染的下一代噬菌体鸡尾酒项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"1187953494","title":"BiomX提供项目更新并宣布新的FDA反馈，可能扩展Bx004的开发路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1187953494","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187953494?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:31","pubTimestamp":1760704270,"startTime":"0","endTime":"0","summary":"BiomX提供项目更新并宣布新的FDA反馈，可能扩展Bx004的开发路径","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2568821213","title":"Biomx Inc.盘中异动 下午盘大幅上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568821213","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568821213?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:31","pubTimestamp":1758306666,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时31分，Biomx Inc.股票出现异动，股价急速上涨5.54%。截至发稿，该股报0.537美元/股，成交量24.0766万股，换手率0.91%，振幅5.31%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023106979d9fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023106979d9fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2565758523","title":"Biomx Inc.盘中异动 早盘股价大跌5.29%报0.503美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565758523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565758523?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:44","pubTimestamp":1756993460,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日21时44分，Biomx Inc.股票出现波动，股价急速下跌5.29%。截至发稿，该股报0.503美元/股，成交量4.3533万股，换手率0.16%，振幅1.83%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904214420a4b414bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904214420a4b414bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2558766619","title":"Biomx Inc.盘中异动 快速拉升5.23%报0.500美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558766619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558766619?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:35","pubTimestamp":1754919317,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时35分，Biomx Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报0.500美元/股，成交量41.1018万股，换手率1.57%，振幅4.21%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112135189740e4f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112135189740e4f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2558506545","title":"Biomx Inc.8月8日成交额为222.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558506545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558506545?lang=zh_cn&edition=full","pubTime":"2025-08-09 13:14","pubTimestamp":1754716472,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Biomx Inc.成交额为222.87万美元，成交额较昨日减少67.12%，当日成交量为455.15万股。Biomx Inc.于2025年8月8日跌20.01%，报0.475美元，该股过去5个交易日涨19.66%，年初至今跌34.92%，过去60日跌11.21%。BX004 是正在开发的治疗性噬菌体候选产品，用于治疗由铜绿假单胞菌或铜绿假单胞菌引起的慢性肺部感染，其中铜绿假单胞菌是导致 CF 患者发病率和死亡率的主要原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809131436a6dc1f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809131436a6dc1f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2557535255","title":"Biomx Inc.8月6日成交额为1.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557535255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557535255?lang=zh_cn&edition=full","pubTime":"2025-08-07 13:06","pubTimestamp":1754543163,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Biomx Inc.成交额为1.23亿美元，成交额较昨日增加1302.94%，当日成交量为1.99亿股。Biomx Inc.于2025年8月6日涨49.43%，报0.65美元，该股过去5个交易日涨59.31%，年初至今跌10.96%，过去60日涨25.97%。BX004 是正在开发的治疗性噬菌体候选产品，用于治疗由铜绿假单胞菌或铜绿假单胞菌引起的慢性肺部感染，其中铜绿假单胞菌是导致 CF 患者发病率和死亡率的主要原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807130614a47a1fa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807130614a47a1fa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2557370967","title":"Biomx Inc.盘中异动 早盘快速拉升29.06%报0.561美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557370967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557370967?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:31","pubTimestamp":1754487084,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时31分，Biomx Inc.股票出现异动，股价大幅上涨29.06%。截至发稿，该股报0.561美元/股，成交量7128.29万股，换手率272.32%，振幅9.82%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213124a478d7d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213124a478d7d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2556380942","title":"Biomx Inc.盘中异动 早盘大幅拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556380942?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:26","pubTimestamp":1754317605,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时26分，Biomx Inc.股票出现波动，股价大幅拉升5.88%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804222645a6d298c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804222645a6d298c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2555396808","title":"Biomx Inc.盘中异动 早盘快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555396808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555396808?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:58","pubTimestamp":1753970306,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时58分，Biomx Inc.股票出现异动，股价大幅下跌5.10%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为2.33%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215826a46dbf5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731215826a46dbf5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2555685270","title":"Biomx Inc.盘中异动 临近午盘大幅下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555685270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555685270?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:50","pubTimestamp":1753804254,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时50分，Biomx Inc.股票出现异动，股价急速下挫5.31%。截至发稿，该股报0.410美元/股，成交量10.8251万股，换手率0.41%，振幅4.30%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292350559725baa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292350559725baa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2552343635","title":"Biomx Inc.盘中异动 大幅拉升6.34%报0.407美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552343635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552343635?lang=zh_cn&edition=full","pubTime":"2025-07-18 01:51","pubTimestamp":1752774685,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日01时51分，Biomx Inc.股票出现波动，股价快速上涨6.34%。截至发稿，该股报0.407美元/股，成交量39.7004万股，换手率1.52%，振幅8.22%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718015126a6b04e75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718015126a6b04e75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2551125566","title":"Biomx Inc.盘中异动 早盘大幅跳水5.00%报0.380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551125566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551125566?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:32","pubTimestamp":1752672756,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时32分，Biomx Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报0.380美元/股，成交量11.4054万股，换手率0.44%，振幅0.10%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162132369544eaea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162132369544eaea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomx.com","stockEarnings":[{"period":"1week","weight":-0.2327},{"period":"1month","weight":-0.65},{"period":"3month","weight":-0.8154},{"period":"6month","weight":-0.8055},{"period":"1year","weight":-0.8378},{"period":"ytd","weight":-0.8645}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BiomX Inc.于2017年11月1日根据特拉华州法律成立。2019年10月28日，该公司与BiomX Ltd.合并，然后更名为BiomX Inc.。该公司正在开发天然和工程化的噬菌体混合物，旨在针对和消灭慢性疾病中的有害细菌，目前主要致力于囊性纤维化，并在较小程度上致力于特应性皮炎。该公司发现并验证专有细菌靶点，并针对这些靶点定制噬菌体组合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.142121},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.019639},{"month":3,"riseRate":0.333333,"avgChangeRate":0.132083},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.052316},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.104594},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.042142},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.028521},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.072801},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.126957},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.11497},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.17671},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.096931}],"exchange":"AMEX","name":"BiomX Inc.","nameEN":"BiomX Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BiomX Inc.(PHGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BiomX Inc.,PHGE,BiomX Inc.股票,BiomX Inc.股票老虎,BiomX Inc.股票老虎国际,BiomX Inc.行情,BiomX Inc.股票行情,BiomX Inc.股价,BiomX Inc.股市,BiomX Inc.股票价格,BiomX Inc.股票交易,BiomX Inc.股票购买,BiomX Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BiomX Inc.(PHGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}